BioSpace News Archive

Drug Development

Castle Creek Pharma Announces Data Validating First Investigator’s Global Assessment Scale for Epidermolysis Bullosa Simplex Clinical Research

Results are being presented at the Winter Clinical Dermatology Conference held January 12-17, 2018 at the Hyatt Regency Maui in Hawaii.

January 15, 2018
·
3 min read
Pharm Country

Olympus PeriView FLEX TBNA Needle Brings New Capabilities to Early Diagnosis of Lung Disease

The device features Olympus’ FLEX-cut technology, an innovation leveraging a spiral pattern of laser cuts on the needle, for unprecedented flexibility.

January 15, 2018
·
4 min read
Business

e-Therapeutics to Collaborate With Intellegens and Biorelate to Enhance and Extend its AI Technology Capabilities

The collaboration will allow e-Therapeutics to apply Intellegens’ technology to the predication and error correction of large-scale biological and chemical data.

January 15, 2018
·
2 min read
Conversion of FIT Biotech Oy’s Convertible Capital Notes Into Shares

The K shares will be admitted to trading on First North Finland on or about January 16, 2018.

January 15, 2018
·
1 min read
Google Backs Vaccitech’s $27M Series A Funding Round

Vaccitech is an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products.

January 15, 2018
·
3 min read
FDA

Teva Wins FDA Nod for TRISENOX (arsenic trioxide) Injection for First Line Treatment of Acute Promyelocytic Leukemia

The approval was based on a Priority Review by the FDA on data from published scientific literature and a review of Teva’s global safety database for arsenic trioxide.

January 15, 2018
·
11 min read
Business

MPI’s Spinout Oncology Venture Will Execute License to Multi TKI Phase III Compound

Oncology Venture has decided to execute the TKI license which has already been negotiated.

January 15, 2018
·
4 min read
Business

Scythian Biosciences Announces CEOs of Both Aphria and Liberty Health Sciences are Joining its Board

Along with their great expertise and backgrounds, Mr. Neufeld and Mr. Scorsis will also bring to Scythian new relationships and allow Scythian to expand its business globally.

January 15, 2018
·
6 min read
Business

Xbrane Biopharma Clarifies Information Regarding Letter of Intent With CR Pharma Considering Xlucane

Xbrane signed the 7th of December 2017 a non-binding letter of intent with CR Pharma regarding out-licensing of Xlucane for the Chinese market.

January 15, 2018
·
1 min read
AusIndustry Awards Recce Support for AU$5.6m of Technically Advanced Overseas Drug Development

The funds include and cover some expenditure already undertaken and apply to all antibiotics under development.

January 15, 2018
·
1 min read